Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB
CB2 cannabinoid receptor
CB2 receptor allosteric modulators
CB2 receptor ligands
Endocannabinoid system
Neurodegenerative disorders
Neuroprotection
Phytocannabinoids
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
10
01
2021
revised:
12
03
2021
accepted:
06
04
2021
pubmed:
6
6
2021
medline:
15
2
2022
entrez:
5
6
2021
Statut:
ppublish
Résumé
In the last decades, cannabinoid receptor 2 (CB
Identifiants
pubmed: 34089867
pii: S1043-6618(21)00191-2
doi: 10.1016/j.phrs.2021.105607
pii:
doi:
Substances chimiques
Endocannabinoids
0
Ligands
0
Neuroprotective Agents
0
Receptor, Cannabinoid, CB2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105607Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.